Cytotoxicity Tests, Immunologic
Research News and Information

Sunday, November 22, 2009

HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.

30 Aug 2009 The aim of this retrospective study is to assess the frequency of HLA-B27 and HLA-B51 in healthy subjects from the center of Tunisia and to investigate their usefulness in the diagnosis of ankylosing spondylitis (AS) and Behçet's disease (BD), ... Read more...

Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.

30 Aug 2009 T cells can be engineered to express the genes of chimeric antigen receptors (CARs) that recognize tumor-associated antigens. We constructed and compared 2 CARs that contained a single chain variable region moiety that recognized CD19. One CAR ... Read more...

Development of highly sensitive Bicistronic vector based non-radioactive antigen-specific cytotoxicity assay.

11 Aug 2009 In the absence of a better alternate, (51)Cr release assay, with its several disadvantages is still the most common method for detection of MHC class I restricted T-cell mediated cytotoxicity. We describe a system in which the T-cell mediated ... Read more...

Latest indexed articles for 'Cytotoxicity Tests, Immunologic'

These are the very latest articles for this heading:

• HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease. 30 Aug 2009
• Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor. 30 Aug 2009
• Development of highly sensitive Bicistronic vector based non-radioactive antigen-specific cytotoxicity assay. 11 Aug 2009
• Geranylated flavonoids from the roots of Campylotropis hirtella and their immunosuppressive activities. 10 Aug 2009
• Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. 10 Aug 2009
• High frequencies of functionally competent circulating Tax-specific CD8+ T cells in human T lymphotropic virus type 2 infection. 3 Aug 2009
• In vitro tests in drug hypersensitivity diagnosis. 30 Jul 2009
• Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity. 30 Jul 2009
• T cell activation by heat shock protein 70 vaccine requires TLR signaling and scavenger receptor expressed by endothelial cells-1. 27 Jul 2009
• Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL. 18 Jul 2009
• A novel mouse model for immunogenic evaluation of human HBV vaccines. 13 Jul 2009
• Which human leukocyte antigen antibodies are really clinically relevant? 2 Jul 2009
• CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model. 29 Jun 2009
• Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis. 28 Jun 2009
• Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. 22 Jun 2009
• Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factor. 21 Jun 2009
• Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma. 20 Jun 2009
• Immunotoxicological effects of an activated-sludge-treated effluent on rainbow trout (Oncorhynchus mykiss). 16 Jun 2009
• Defining the mechanism(s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame. 16 Jun 2009
• Stable expression of EBV-gp350 on the surface of NC37 cells confers natural killer (NK)-cell susceptibility or resistance, depending on the assay used to assess NK-mediated function. 15 Jun 2009

See a longer list of these articles.

Technical information about 'Cytotoxicity Tests, Immunologic'

Definition: The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement.

Descriptor UI: D003601

Alternative terms: Cytotoxicity Tests, Immunologic; Immunologic Cytotoxicity Test; Cytotoxicity Tests, Immunological; Cytotoxicity Test, Immunological; Immunological Cytotoxicity Test; Immunological Cytotoxicity Tests; Cytotoxicity Test, Immunologic; Immunologic Cytotoxicity Tests; Lymphocytotoxicity Tests, Antiglobulin-Augmented; Lymphocytotoxicity Tests, Antiglobulin Augmented; Antiglobulin-Augmented Lymphocytotoxicity Tests; Antiglobulin Augmented Lymphocytotoxicity Tests; Lymphocytotoxicity Test, Antiglobulin-Augmented; Lymphocytotoxicity Test, Antiglobulin Augmented; Antiglobulin-Augmented Lymphocytotoxicity Test; Antiglobulin Augmented Lymphocytotoxicity Test; Microcytotoxicity Test; Microcytotoxicity Tests; Anti-Human Globulin Complement-Dependent Cytotoxicity Tests; Anti Human Globulin Complement Dependent Cytotoxicity Tests; Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent; Cytotoxicity Tests, Anti Human Globulin Complement Dependent; AHG-CDC Tests; AHG CDC Tests; AHG-CDC Test; Anti-Human Globulin Complement-Dependent Cytotoxicity Test; Anti Human Globulin Complement Dependent Cytotoxicity Test;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics;

Tree Number: E01.450.495.160; E05.478.594.160; E05.940.245;

History Note: 73(71)

Technical Notes: note category: do not confuse with CYTOTOXICITY, IMMUNOLOGIC (Cat G); DF: CYTOTOX TESTS IMMUNOL